Log ind

Qualcomm chief: This is the future

Top picks in English:

The General Manager of the healthcare division in Qualcomm, the world’s largest wireless technology group, offers his view on how healthcare technology will evolve in the future.


by Leonora Beck
Offentliggjort 20.05.14 kl. 14:31

Log ind for at læse artikler

Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.

Prøv os gratis i 14 dage

Få fuld adgang til vores kvalitetsjournalistik med et gratis prøveabonnement.

Sign up for MedWatch newsletter
Mest læste Top picks in English

Here is what Danish drug companies pay their workers

Løn Top picks in English:

The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.

Biotech and CRO outfit Gubra continues explosive growth

Top picks in English:

Thanks to a successful gamble on one particular niche, Denmark’s Gubra has managed to quadruple its employee base in just a few years. The two-pronged business is set to expand significantly in the future.

Novo Nordisk jumps on the discount wagon

Top picks in English:

Novo Nordisk’s US unit has struck a deal with CVS Health for a new savings program that will give some patients up to 80 percent reduction on some of the group’s insulin products. It thus looks like times are changing in the Denmark-based insulin giant.

“You have to remember that investment is a long-term business”

Top picks in English:

Although its asset value and net result both dipped significantly in 2016, the new CEO of Novo A/S, Kasim Kutay, is very optimistic on behalf of the company. The long-term trend looks good, he says, and the company is ready to increase investments and bridge the gap between two of its units.

BioPorto chief: ”Strategically, it’s of exceptional importance”

Top picks in English:

BioPorto has released two positive announcements in the span of a week, and more are set to follow as the diagnostics company intends to increase its news flow in the run-up to a pivotal US approval.

Saniona gets go ahead for phase IIa trial in obesity disorder

Top picks in English:

Danish biotech Saniona is ready to initiate phase II studies of its lead candidate in a rare disease that leads to obesity and type 2 diabetes. The company aims to add additional endpoints to the study.

Forsiden lige nu

Trump beder republikanere trække sundhedsreform tilbage

donaldtrump10.jpg Medicinal & Biotek:

Republikanerne kunne ikke samle stemmer nok til at få erstatning for Obamacare vedtaget.

Genmabs topchef gør sin vækstfilosofi klar

Medicinal & Biotek:

Jan van de Winkel sætter tal på, hvor mange af sine ansattes ægtefæller, han kender. Vi skal mødes på trapperne, siger topchefen om sin ledelsesstrategi.

Novo-chef: Trump forstår ikke kompleksiteten i alt, han udtaler sig om

Medicinal & Biotek:

Medicinalindustrien og Novo Nordisk specifikt er blevet udråbt som de store skurke i USA, hvor beskyldninger om grådighed nærmest er blevet hverdag. Verden er dog noget mere kompleks end det.

MW-indeks: Få pæne stigninger i en rød uge

Medicinal & Biotek:

Den den danske medicokoncern Coloplast var lokomotivet, der trak life science-toget på børspladsen i den forgangne uge, mens en anden ellers vækstforvænt aktør måtte se sin aktiekurs dykke.

Nyt land melder sig i konkurrencen om EMA

Medicinal & Biotek:

København har fået endnu en konkurrent om at overtage det Europæiske Lægemiddelagentur, når Storbritannien melder sig ud af EU. Denne gang er det et land, som argumenterer for, at det ikke har et agentur i forvejen.

Almirall indsender ansøgning for psoriasishåb

Medicinal & Biotek:

Den spanske medicinalkoncern Almirall og partneren Sun Pharma har taget det første skridt mod en europæisk godkendelse af deres biologiske lægemiddel til behandling af psoriasis.

ANNONCE
ANNONCE


ANNONCE